DesignMedix: Overcoming Drug Resistance
DesignMedix places great emphasis on tackling problems of drug resistant diseases, such as malaria, bacteria, and cancer.
DesignMedix places great emphasis on tackling problems of drug resistant diseases, such as malaria, bacteria, and cancer.
The first start-up by Bob Ward—The Polymer Technology Group (PTG)—earned a 555X return for investors upon its sale in 2008 to DSM, the global life sciences and materials company. Now, Bob Ward’s swinging away at another potential homerun: ExThera Medical, a Berkeley, California-based company, with its scientific origins at the Karolinska Institute in Stockholm, Sweden.
IBM and a research group in Singapore have engineered a new kind of nano particle that could attack bacteria that have become resistant to antibiotics.
MicroPhage is a medical devices company that has developed advanced diagnostic technology for detection of bacterial infections and their antibiotic susceptibility. The company’s novel mechanism […]
Tennessee became the fourth state to be hit by the E. coli outbreak caused by tainted Romaine lettuce, USA Today reported on Thursday.
Copyright © 2024 | WordPress Theme by MH Themes